Colorants in Medical Devices:
|
|
- Dulcie Wilson
- 6 years ago
- Views:
Transcription
1 Colorants in Medical Devices: The Spectrum of Current Regulatory Expectations John Iannone Program Manager/ Technical Specialist
2 Overview» Company Introduction» Why use Colorants in Devices?» Regulatory Testing Considerations» So now What s the Big Deal, again?» Meeting Regulatory Expectations 1
3 TOXIKON COMPANY PROFILE» C.R.O. Headquarters: Bedford, MA» European Lab Facility: Leuven, Belgium» Nearly 40 yrs of experience in Medical Device & Pharma Industry Biocompatibility Material Characterization (E&L) Toxicology Microbiology» FDA Registered» ISO Accredited» GLP & GMP Compliant testing» > 150 Researchers 2
4 Colorants in Medical Devices
5 Colorants in Devices 4 CONFIDENTIAL
6 Colorants in Medical Devices» Medical Device Manufacturers have many uses for including Pigments & Colorants in Medical Devices.. Improvement on Ease of use Identification of product type/ size/ etc. Marketing and visual appeal Opacity/visualization» FDA requires all Devices to be Safe Biocompatibility (ISO 10993)» Any change in additives can have an impact on Biocompatibility Why? 5
7 Biocompatibility» Simplest Viewpoint: Material is biologically compatible by not eliciting a local or systemic response from a living system or tissue.» Regulatory Viewpoint: Series of tests used to identify potentially adverse reactions of material/device contacting the body. The leachates of a device, or the device itself, should not produce adverse local, systemic, tumorgenic, reproductive, or developmental effects. 6
8 Test Article Preparation for Biocompatibility Testing» In biocompatibility testing for regulatory submission, test articles should be finished devices ready for the market» Most tests are performed with extractions created from the finished device (ISO )» Extractions should occur at the highest feasible temp/time condition the regulations provide as options (ie. 70⁰C/24 hrs)» Polar & non-polar extraction vehicles are required (solubility) Utilized to mimic various environments in the body 7
9 Biocompatibility of Material/Devices ISO 10993» Cytotoxicity» Sensitization» Irritation & Intracutaneous Reactivity» Acute Systemic Toxicity» Subacute & Subchronic Systemic Toxicity» Genotoxicity» Implantation Reactivity» Hemocompatibility» Chronic Systemic Toxicity» Carcinogenicity 8
10 Leachate Migration/ Extraction Polymer Migration Extraction Solution Environment of Concern 9
11 Biocompatibility & Material Characterization» Biocompatibility per ISO Assess Specific Mechanisms for Biological Reactivity Material Focused Typically polymeric devices are extracted in assay Extractables/Leachables Determine leachates pre/post interactions between material, sterilization, aging, environmental effects Characterize WHAT may be of a safety concern - Material Selection - Submission Support» Toxicology per OECD, ISO etc. Toxicological effects of drug, biologic, chemical entity Evaluation of leachates found during product use to demonstrate safe and allowable limits 10
12 So what is the Big Deal?
13 FDA Position on Color Additives for Medical Devices» Under certain conditions, color additives in medical devices are subject to the same provisions that apply to color additives in foods, drugs and cosmetics. The Food, Drug and Cosmetic (FD&C) Act states that devices containing a color additive are considered unsafe, and thereby adulterated, unless a regulation is in effect listing the color additive for such use. The FD&C Act limits applicability of these provisions to color additives that directly contact the body for a significant period of time. At the present time, the term a "significant period of time" is not defined by FDA regulation.» For the purposes of enforcing adulteration provisions under the FD&C Act, unless the color additive and its use conform to a listing regulation under Title 21 of the Code of Federal Regulations (CFR) Parts 73 and 74, including any provision of such regulation prescribing the conditions under which the color additive may be safely used. The color listing regulation may permit use of the color additive in a generic type of device, such as contact lenses, or may place limitations on its use, such as polypropylene nonabsorbable sutures for general surgical use but not for ophthalmic surgical use.» A color additive subject to the provisions under section 721 of the FD&C Act is deemed unsafe The 21 CFR Parts 1 to 99 (includes Parts 70,71,73,74 & 80) 12
14 FDA Position on Color Additives for Medical Devices» Draft Guidance for Industry and Food and Drug Administration Staff issued in April of 2013 Use of International Standard ISO-10993, Biological Evaluation of Medical Devices Part 1: Evaluation and Testing Section 7: Assessment of Known or Potentially Toxic Chemical Entities For chemicals used in a device for the first time, or for chemicals with known or potential toxicities (e.g., color additives, or drugs used in combination products), additional information should be provided to determine whether toxicology information beyond standard biocompatibility testing is needed 13
15 Extractables and Leachables Sources COMPOSITION OF COMMERCIAL POLYMERS o Additives o Residues o Oligomers o Degradation Compounds from Polymers o Degradation Compounds from Polymer Additives 14
16 Extractables and Leachables Sources Anti-Oxidants Plasticizers Photostabilizers Slip Agents Antiozonants Coupling Agents Lubricants Acid Scavengers Peroxides / Crosslinkers Blowing Agents Pigments/Colorants Antistatic Agents Metal Chelators Adhesives Bactericides Clarifying Agents Antifogging agents Fillers (Red: coming with some examples) 15
17 Extractables and Leachables Sources Pigments / Colorants Function: Gives the polymer/material the desired color Carbon Black (PNA s!) TiO 2 (white) Fe 2 O 3 (red) Pigment Green 07 Solvent Red Solvent yellow 114 Solvent Green 03 Colorants have unique formulations: Include Ink/Pigment, Carrier, etc 16
18 Leaching of Additives Diffusion 17
19 Understanding Extractables & Leachables
20 MATERIAL QUALIFICATION/BIOCOMPATIBILITY/E&L SOURCES OF LEACHATES» Polymer Additives Antioxidants, Slip Agents, UV Stabilizers, Plasticizers, Colorants» Polymer Degradation Products Sterilization, Storage, Processing» Residues Monomers, Catalyst, Solvents» Manufacturing Impurities Cleaners, Hydrocarbons» Migration from Secondary Contacting Material Adhesive, Ink, Multi-film, Nonhomogeneous Material, Packaging 19
21 Extractable/Leachable Sources Potential Inorganic Compounds of concerns Metals If you don t look for it, you won t find it! 20
22 Analytical Methods for E&L Determination FIRST PASS Testing for Extractable Studies Try to Fully Characterize the Extraction Profile of material, using: Standard Analytical Equipment, e.g. 1. Headspace GC/MS 2. GC/MS 3. LC/MS 4. ICP 5. Ion Chromatography Optimized Procedures & Procotols» Leverage Compound Database (ie:tox-ray) for First Pass Analytical Techniques built on expertise & high volume of studies allows high level ID in First Pass Standardized Methods combined with Targeted Analysis Efficiency/Cost effectiveness is Key in FIRST PASS Experiments
23 Understand what is happening Extractable Testing» Identify the potential compounds extracted into model solvents under aggressive conditions» Determine which, if any, compounds may affect patient or product Leachable Testing» Measure actual amount of leached compounds as a function of time» Determine How Much of What is present and: Does exposure to the patient affect safety? Tox Assessment 22
24 Risk Assessments
25 Risk Assessment of Medical Devices 2 complimentary, but not overlapping, areas that the Sponsor is expected to evaluate via risk assessment ISO (2009) Evaluation and testing within a risk management process ISO (2002) Establishment of Allowable Limits for Leachable Substances 24 CONFIDENTIAL
26 Risk Assessment of Medical Devices ISO Determines safety of proposed device & recommends testing as needed from ISO/FDA requirements» Evaluate device materials (component breakdown)» Consider history of clinical use» Identifies data gaps Performed at the beginning of device development, often to guide material selection & test program 25 CONFIDENTIAL
27 Risk Assessment of Medical Devices ISO Used as a follow-up to extractables and/or leachables testing (ISO )» Review safety information for all identified compounds» Set limits of safe exposure» Compare limits to amounts seen in E&L data Can be used to give a green light to continued product development once extractables are identified 26 CONFIDENTIAL
28 So which Colorants are considered acceptable? Approved for Specific Uses with Batch Certification 27 CONFIDENTIAL
29 So which Colorants are considered acceptable? Approved for Specific Uses Batch Certification Exempt 28 CONFIDENTIAL
30 Options in Meeting Regulatory Expectations» Full Biocompatibility on each Device Configuration (every color) & Technical Evaluation of each Colorant» Full Biocompatibility on 1 Device Configuration with Chemical Characterization of each Device Configuration (each color) & Toxicological Risk Assessment of the full package» Full Biocompatibility on 1 Device Configuration with a Toxicological Risk Assessment of additives (each of the colors)» Conduct pooled Biocompatibility on Multiple Device Configuration, with a modified (more aggressive) Extraction ratio that ensures individual configurations are not diluted & Technical Evaluation of each Colorant 29
31 Conclusion Colorants, Inks, & Pigments, are considered additives in Medical Devices Understanding & full characterizing these additives through Identification, Elution Characterization, & Patient Safety determination will satisfy regulatory expectations/ requirements. Biocompatibility may be leverage along with Chemical Characterization to evaluate more than one device configuration (when only a single difference exists) Toxicological Risk Assessment of Device additives can be sufficient with good info & exaggerating conditions of use. 30
32 Thank you John Iannone Program Manager 15 Wiggins Ave, Bedford, MA x
How to Prepare MedDevice Packaging for Regulatory Success A Chemical Characterization (E&L) Perspective
How to Prepare MedDevice Packaging for Regulatory Success A Chemical Characterization (E&L) Perspective Frank Bieganousky, AMRI Wei Zhang, Ph.D., AMRI Purpose» Demonstrate a proactive approach for integration
More informationGreenPla Positive List (PL) Formulation Standards. (Includes Compostable GreenPla)
GreenPla Positive List (PL) Formulation Standards (Includes Compostable GreenPla) April 2000 (1st Edition) February 2013 (Revised) November 2018 (Revised) Japan BioPlastics Association 1. Tabulation Policy
More informationUnited States Pharmacopeia: Revision Process for USP Biocompatibility General Chapters <87>, <88> and <1031>
United States Pharmacopeia: Revision Process for USP Biocompatibility General Chapters , and Daniel L. Norwood, M.S.P.H, Ph.D. USP Packaging and Distribution Expert Committee Executive
More informationTesting and Evaluation Strategies for the Biological Evaluation of Medical Devices submitted for CE Mark and FDA Approval
Testing and Evaluation Strategies for the Biological Evaluation of Medical Devices submitted for CE Mark and FDA Approval Today, millions of medical devices are used worldwide to treat or support patients.
More informationPHARMACEUTICAL TESTING
WHITEHOUSE, NJ PHARMACEUTICAL TESTING Pharmaceutical Expertise for GMP & CMC Testing Our Pharmaceutical Expertise With more than 20 years of experience in a variety of industries, our Whitehouse, New Jersey
More informationOMICS International Conferences
About OMICS Group OMICS Group is an amalgamation of Open Access Publications and worldwide international science conferences and events. Established in the year 2007 with the sole aim of making the information
More informationConsiderations for Ophthalmic Drug Products in Semi-Permeable Packaging
Considerations for Ophthalmic Drug Products in Semi-Permeable Packaging Bausch + Lomb Thresholds and Best Practices for Parenteral and Ophthalmic Drug Products (PODP) February 22-23, 2011 Bethesda 23/02/2011
More informationISO : A Risked Based Approach to Biological Safety
ISO 10993 : A Risked Based Approach to Biological Safety Dr Arthur Brandwood Australian Delegation Leader to ISO TC 194 Biocompatibility and Clinical Trials Previous Director Devices Registration and Assessment
More informationRisk Management of Biological Evaluation What s the Future for ISO 10993?
Risk Management of Biological Evaluation What s the Future for ISO 10993? ISO 10993 High level guidance on how to conduct a biological evaluation Detailed test methods for investigation of different aspects
More informationValidation Needs for Sterilization by Aseptic Filtration
Validation Needs for Sterilization by Aseptic Filtration DCVMN Workshop, Hyderabad, 4-8 April 2016 Ramesh Raju Associate Director - Provantage Validation Services Overview Key Regulatory and Industry guidelines
More informationISO INTERNATIONAL STANDARD
INTERNATIONAL STANDARD ISO 10993-13 Second edition 2010-06-15 Biological evaluation of medical devices Part 13: Identification and quantification of degradation products from polymeric medical devices
More informationPrecision. Proficiency. Proximity.
Precision. Proficiency. Proximity. Precision Accuracy in testing is paramount to ensuring product safety and efficacy. And fast turnaround times are critical to keeping your project on schedule. With
More informationExtractable and Leachable Challenges From a generic injectable drug development perspective
Extractable and Leachable Challenges From a generic injectable drug development perspective Andrea Redd Director, US Regulatory Affairs Fresenius Kabi November 8, 2017 Disclaimer This presentation contains
More informationPQRI Workshop: Leachables and Extractables
PQRI Workshop: Leachables and Extractables Rockville, Maryland December 5-6, 2005 Best Practices Recommendation: Regulatory Science Strategies Guirag Poochikian, Ph.D. Office of New Drug Quality Assessment
More informationPQRI PODP Extractables & Leachables Workshop Sources of Leachables for Injectable and Ophthalmic Container Closure Systems
PQRI PDP Extractables & Leachables Workshop Sources of Leachables for Injectable and phthalmic Container Closure Systems Presented by: Michael Ruberto, President Material Needs Consulting April 2018 Packaging-Container
More informationSatisfying ISO and US FDA Biocompatibility requirements for Breathing Gas Pathways in Healthcare Application
Satisfying ISO 18562 and US FDA Biocompatibility requirements for Breathing Gas Pathways in Healthcare Application Audrey Turley, B.S., RM (NRCM), CBA Biocompatibility Expert 801-290-7907 aturley@nelsonlabs.com
More informationCERTIFICATE OF ACCREDITATION
CERTIFICATE OF ACCREDITATION ANSI-ASQ National Accreditation Board 500 Montgomery Street, Suite 625, Alexandria, VA 22314, 877-344-3044 This is to certify that Toxikon Corporation 15-25 Wiggins Avenue
More informationDerivation and Justification of Safety Thresholds
Derivation and Justification of Safety Thresholds Douglas J. Ball, MS, DABT Chair, PQRI L&E Toxicology Subgroup Research Fellow, Safety Sciences - Pfizer, Inc. Agenda Basic Definitions Current Regulatory
More informationLeachable and Extractable Testing
Leachable and Extractable Testing A Primer on Regulations and Methods As presented to By: Anthony Grilli, MS General Manager SGS LSS NJ Laboratory 973 244 2435 Anthony.Grilli@SGS.com Summary Why perform
More informationSGS Delivering Excellence in Compliant Extractables and Leachables Testing
SGS CASE STUDY SGS Delivering Excellence in Compliant Extractables and Leachables Testing A case study in unknown impurity identification & quantification SGS is a world leading inspection, verification,
More informationDeveloping a Best Practice Guide for Leachables Risk Assessment, Study Design, and Analytical Methods
Developing a Best Practice Guide for Leachables Risk Assessment, Study Design, and Analytical Methods Single-use systems (SUS) offer biopharmaceutical manufacturers significant gains in process flexibility,
More informationMedical Devices INNOVATIVE SOLUTION FOR THE HEALTHCARE
Medical Devices INNOVATIVE SOLUTION FOR THE HEALTHCARE Medical Devices The new Regulation 745/2017 defined as Medical Device any instrument, apparatus, appliance, software, implant, reagent, material or
More informationThe Use of BPOG Generated Extractables Data for Toxicological Assessment
The Use of BPOG Generated Extractables Data for Toxicological Assessment Sade Mokuolu, Ph.D Group Product Compliance Manager, WMFTG PDA Brazil 2017 Disclaimer This presentation is the copyright information
More informationServices for Medical Devices. Expert solutions for product development from concept to commercialization
Services for Medical Devices Expert solutions for product development from concept to commercialization Services for Medical Devices WuXi AppTec s comprehensive testing programs and expert guidance help
More informationDealing with Extractables & Leachables from a Regulatory Perspective - Design of Extractables & Leachables Studies - Safety Assessment of Leachables
Dealing with Extractables & Leachables from a Regulatory Perspective - Design of Extractables & Leachables Studies - Safety Assessment of Leachables Timothy W. Robison, Ph.D., D.A.B.T. Division of Pulmonary,
More informationISO INTERNATIONAL STANDARD
INTERNATIONAL STANDARD ISO 10993-9 Second edition 2009-12-15 Biological evaluation of medical devices Part 9: Framework for identification and quantification of potential degradation products Évaluation
More informationCONTRACT ANALYTICAL SERVICES
CONTRACT PFOA/PFOS (Perfluorinated Alkyl Acid) Testing United Science contract from and through polymeric materials. 2D LC Membrane Permeability Analytical Methods Spectroscopy Custom On-line Instrumentation
More informationAdvanced Materials A Review of What is Applicable in SUT
Advanced Materials A Review of What is Applicable in SUT Amy Plancon, Jayanthi Grebin, and James Hicks Panel Organizer: Eva Heintz, Ph.D. Thermoplastics: General Polyolefins Amy Plancon Sabic July 14,
More informationAccredited Laboratory
Accredited Laboratory A2LA has accredited St. Paul, MN for technical competence in the field of Biological Testing This laboratory is accredited in accordance with the recognized International Standard
More informationBiocompatibility: a risk based approach
Biocompatibility: a risk based approach Legal framework The regulatory requirements include: Demonstration of safety Demonstration of efficacy Positive balance of risk and benefit The regulatory requirements
More informationISO INTERNATIONAL STANDARD. Biological evaluation of medical devices Part 1: Evaluation and testing within a risk management process
INTERNATIONAL STANDARD ISO 10993-1 Fourth edition 2009-10-15 Biological evaluation of medical devices Part 1: Evaluation and testing within a risk management process Évaluation biologique des dispositifs
More informationThe clear choice for renal device applications.
The clear choice for renal device applications. What you see. Premature cracking and breakage in renal device housings not only present an economic challenge for hospitals, clinics, and device manufacturers
More informationBiocompatibility Testing for Medical Devices
Biocompatibility Testing for Medical Devices *** LIMITED TIME OFFER: FREE $100 AMAZON GIFT CARD! *** REGISTER TODAY! The medical device field is one of the most heavily regulated industries, for obvious
More informationBiocompatibility Testing for Medical Devices
Biocompatibility Testing for Medical Devices *** LIMITED TIME OFFER: FREE $100 AMAZON GIFT CARD! *** REGISTER TODAY! The medical device field is one of the most heavily regulated industries, for obvious
More informationMedical Device Testing. Andrew Makin, MSc, ERT, MRSB Scientific Director CiToxLAB Scantox, Denmark
Medical Device Testing Andrew Makin, MSc, ERT, MRSB Scientific Director CiToxLAB Scantox, Denmark Medical device Risk evaluation Efficacy Biocompatibility Clinical testing Pharmaceutical product Preclinical
More informationBiological evaluation of medical devices. Part 11: Tests for systemic toxicity
Provläsningsexemplar / Preview INTERNATIONAL STANDARD ISO 10993-11 Third edition 2017-09 Biological evaluation of medical devices Part 11: Tests for systemic toxicity Évaluation biologique des dispositifs
More informationFast Facts. Trinseo MAGNUM ABS Resins (Acrylonitrile Butadiene Styrene) for Medical Applications
Fast Facts Trinseo MAGNUM ABS Resins (Acrylonitrile Butadiene Styrene) for Medical Applications Fast Facts Unique Advantages for the Medical Market As the demand for attractive medical equipment grows,
More informationExtractable and Leachable Studies of Parenteral Infusion and Transfusion Products
Extractable and Leachable Studies of Parenteral Infusion and Transfusion Products Jianfeng Hong Fresenius Kabi USA LLC. 3 Corporate Drive, Lake Zurich, Illinois 60047, USA Overview Fresenius Kabi and Products.
More informationTest and Control Article Characterization for Medical Devices. Amy Schade, RQAP-GLP Director Corporate Compliance
for Amy Schade, RQAP-GLP Director Corporate Compliance Disclaimer» This presentation is not intended to encompass all of the requirements of the FDA, EPA, OECD or other regulatory programs for all types
More informationCooperation in the field of toxicology, analytics, R&D and production
Cooperation in the field of toxicology, analytics, R&D and production Where you can find us 2 2 VUOS PARTNER FOR COOPERATION History 3 3 VUOS PARTNER FOR COOPERATION Organizational structure 1. R&D and
More informationTeeramanas Tanaekakarapong, a peritoneal dialysis patient
Teeramanas Tanaekakarapong, a peritoneal dialysis patient Application of ICHQ9 Risk Management Principles to Assess the Risk of Leachables Adversely Impacting the Quality and/or Safety of Complex Biopharmaceuticals
More informationExtractables and Leachables in Early Phase Development
Extractables and Leachables in Early Phase Development Wayland Rushing, Ph.D. Senior Scientific Advisor, ABC 11/23/2015 Product and Process Variants & Impurities 1 Regulatory Perspective Dr. Ingrid Markovic,
More informationEvaluating single-use systems
B i o p r o c e s s Validation Extractables and Leachables from Single-Use Disposables Denise Bestwick and Raymond Colton Evaluating single-use systems for extractables and leachables is new territory
More informationPresentazione: Use of coupled chromatographic analytical. registration of new medicinal products. Relatore: Dr.ssa Federica Bruno
Presentazione: Use of coupled chromatographic analytical techniques (HPLC/MS; GC/MS) in the registration of new medicinal products Relatore: Dr.ssa Federica Bruno date: 21 Ottobre 2016 Public Declaration
More informationGUIDANCE FOR INDUSTRY ON FIXED DOSE COMBINATIONS (FDCs)
GUIDANCE FOR INDUSTRY ON FIXED DOSE COMBINATIONS (FDCs) DRAFT GUIDANCE This guidance document is for feedback purposes only Comments and suggestions regarding this draft document should be submitted within
More information3M Purification Inc. Technical and Scientific Services Global Support for the Life Science Industry. Global Expertise delivered locally
3M Purification Inc. Technical and Scientific Services Global Support for the Life Science Industry Global Expertise delivered locally Global expertise delivered locally As a global leader in measuring,
More information4 Principles for the valuation of the biological evaluation of materials and medical devices
1 Purpose This checklist supplements the process description device certification and regulates the details and approach for the evaluation of the biological evaluation of medical devices in the context
More informationQuality Issues for Clinical Trial Materials: The Chemistry, Manufacturing and Controls (CMC) Review
Quality Issues for Clinical Trial Materials: The Chemistry, Manufacturing and Controls (CMC) Review Presented by Erika E. Englund, Ph.D. Slides courtesy of Dorota Matecka, Ph.D. Office of Pharmaceutical
More informationEarly Development Best Practices for Stability- Regulatory Perspective
Early Development Best Practices for Stability- Regulatory Perspective IQ Workshop, Feb. 4-5, 2014, Washington, D.C. Ramesh Sood, Ph.D. Division Director (Acting) Office of New Drug Quality Assessment
More informationMedical Device Preclinical Bootcamp
Medical Device Preclinical Bootcamp March 30, 2018 9:30am - 2:30pm Massachusetts Biotechnology Council (MassBio) 300 Technology Square, 8th Floor Cambridge, MA 02139 Featured Speakers Rosalyn Año Laurence
More informationRULES FOR POSITIVE LIST
RULES FOR POSITIVE LIST The First Edition Effective: April 2000 BPS Biodegradable Plastics Society 1 1. Policy For Positive List (1) A positive list (PL) is to be compiled respectively by application of
More informationExtractables and leachables: An Introduction
Extractables and leachables: An Introduction Tim Hulme Smithers Rapra THulme@smithers.com 44(0)1939 252 418 1 Extractables and leachables: An Introduction Tim Hulme Smithers Rapra thulme@smithers.com 2
More informationDraft Guidance for Industry and FDA Staff Premarket Notification [510(k)] Submissions for Medical Devices that Include Antimicrobial Agents
Draft Guidance for Industry and FDA Staff Premarket Notification [0(k)] Submissions for Medical Devices that Include Antimicrobial Agents DRAFT GUIDANCE This guidance document is being distributed for
More informationUse of International Standard ISO , "Biological Evaluation of Medical Devices Part 1: Evaluation and Testing"
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 Use of International Standard ISO- 10993, "Biological Evaluation of Medical Devices Part 1: Evaluation and Testing" Draft Guidance
More informationDocumentation requirements for an initial consultation
Language : French or English Documentation requirements for an initial consultation Because of the wide range of medical devices which incorporate, as an integral part, an ancillary medicinal substance,
More informationCGMP Requirements for Investigational Products
PREP #6 CGMP Requirements for Investigational Products Ji-Eun Kim, RPh, PhD Research Pharmacist Regulatory Affairs Office of Research Compliance December 6, 2016 1 CME Disclosure Statement Northwell Health
More informationBIOCOMPATIBILITY TESTING OF GAS PATHWAYS IN MEDICAL DEVICES
BIOCOMPATIBILITY TESTING OF GAS PATHWAYS IN MEDICAL DEVICES EXECUTIVE SUMMARY Many medical devices used to assist in the diagnosis, monitoring or treatment of respiratory issues or to deliver anesthesia
More informationISO/TS TECHNICAL SPECIFICATION
TECHNICAL SPECIFICATION ISO/TS 10993-20 First edition 2006-08-01 Biological evaluation of medical devices Part 20: Principles and methods for immunotoxicology testing of medical devices Évaluation biologique
More informationDesign Perspectives on. Drug/Biologic Delivery. Medtronic Neuromodulation. Luis Fesser Deanna Lane Jeanmarie Sales July 16, 2012
Design Perspectives on Implantable Devices for Targeted Drug/Biologic Delivery Medtronic Neuromodulation Steve Christenson Luis Fesser Deanna Lane Jeanmarie Sales July 16, 2012 The following presentation
More informationCoatings in NL. Regulation and risk assessment of Coating as FCM in The Netherlands. Bianca van de Ven RIVM
Coatings in NL Regulation and risk assessment of Coating as FCM in The Netherlands Bianca van de Ven RIVM Content 1. Regulation of FCM in NL - General provisions - Coating specific provisions 2. Substance
More informationMATERIAL SAFETY DATA SHEET ACCORDANCE TO REGULATION (EC) 1907/2006
VAC-PAK HS 8171-6/66 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND OF THE COMPANY / UNDERTAKING PRODUCT NAME: VAC-PAK HS 8171-6/66 USE OF SUBSTANCE/PREPARATION: RECOMMENDED USE: Co-Extruded High Temperature
More informationRequired Biocompatibility Training and Toxicology Profiles for Evaluation of Medical Devices May 1, 1995 (G95-1)
Required Biocompatibility Training and Toxicology Profiles for Evaluation of Medical Devices May 1, 1995 (G95-1) This guidance was written prior to the February 27, 1997 implementation of FDA s Good Guidance
More informationSafety Qualification Process and Application of Thresholds. Jim Blanchard PQRI L&E Toxicology Subgroup Principal Scientist Aradigm
Safety Qualification Process and Application of Thresholds Jim Blanchard PQRI L&E Toxicology Subgroup Principal Scientist Aradigm Outline Safety qualification process What to do when leachables exceed:
More information3M Drug Delivery Systems. April 26, 2011
3M MDI Manufacturing April 26, 2011 3M Drug Delivery Systems Drug Delivery Systems Overview 3M Drug Delivery Systems is a division of 3M that is dedicated to the development and manufacturing of inhalation
More informationImpact factor: 3.958/ICV: 4.10 ISSN:
Impact factor: 3.958/ICV: 4.10 ISSN: 0976-7908 24 Pharma Science Monitor 8(2), Apr-Jun 2017 PHARMA SCIENCE MONITOR AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES Journal home page: http://www.pharmasm.com
More informationNAMSA is a Medical Research Organization (MRO), accelerating product development
NAMSA is a Medical Research Organization (MRO), accelerating product development through integrated laboratory, clinical and consulting services. Driven by our regulatory expertise, NAMSA's MRO Approach
More informationBiological evaluation of medical devices --
Translated English of Chinese Standard: GB/T16886.1-2011 Translated by: www.chinesestandard.net Wayne Zheng et al. Email: Sales@ChineseStandard.net ICS 11.040.01 C 30 NATIONAL STANDARD OF THE PEOPLE S
More informationConsultation by a notified body on an ancillary medicinal substance integrated in a medical device
Consultation by a notified body on an ancillary medicinal substance integrated in a medical device Documentation requirements for an initial consultation Language : French or English Because of the wide
More informationISO INTERNATIONAL STANDARD. Biological evaluation of medical devices Part 17: Establishment of allowable limits for leachable substances
INTERNATIONAL STANDARD ISO 10993-17 First edition 2002-12-01 Biological evaluation of medical devices Part 17: Establishment of allowable limits for leachable substances Évaluation biologique des dispositifs
More informationIndustry Consortium CB4REACH. Information Letter 3
CB4REACH Industry Consortium CB4REACH Information Letter 3 November 2009 Dear SIEF member, After receiving replies to our second SIEF Information Letter various questions were raised and clarification
More informationLAB EXPERTS AT YOUR SIDE Over twenty years of experience
LAB EXPERTS AT YOUR SIDE Over twenty years of experience About us SYNLAB Pharma offers a broad range of laboratory services to the biotechnology, pharmaceutical and cosmetic industries as well as to manufacturers
More informationEastman medical polymers. Safe and sustainable alternatives for the health care industry
Eastman medical polymers Safe and sustainable alternatives for the health care industry State-of-the-art materials for the world of medical science For generations, Eastman has delivered innovative raw
More informationDirectives 90/385/EEC and 93/42/EEC MEDICAL DEVICES. Guidance document for the presentation of biological evaluation
Directives 90/385/EEC and 93/42/EEC MEDICAL DEVICES Guidance document for the presentation of biological evaluation According to ISO 10993 1 standard (current version) This guidance document is applicable
More informationEstablishing Fitness for Use in a Global Plastic Additives Business
Establishing Fitness for Use in a Global Plastic Additives Business David Horst, Product Stewardship, BASF Corporation Anne Christian, Quality Management, BASF Corporation Dr. Tobias Eltze, Product Stewardship,
More informationInspection Trends. American Society for Quality Richmond, VA Section March 8, 2016
Inspection Trends American Society for Quality Richmond, VA Section March 8, 2016 Brooke K. Higgins, Senior Policy Advisor CDER / Office of Compliance Office of Manufacturing Quality Division of Drug Quality
More informationGuidance Documents for New Chemical Substance Notification in China (China REACH) Non Official
Guidance Documents for New Chemical Substance Notification in China (China REACH) Non Official On 19 Jan 2010, the Ministry of Environmental Protection (MEP) of China released the revised version (MEP
More informationImpact of New ICH Q3D and USP <232> Guidelines for Elemental Impurities Analyses
Impact of New ICH Q3D and USP Guidelines for Elemental Impurities Analyses Content Background... 2 Why should the amounts of elemental impurities be controlled in drug products?... 2 Regulatory requirements...
More informationM-COLOR Colour Masterbatches for Plastics
M-COLOR Colour Masterbatches for Plastics About POLYMER INSTITUTE BRNO Polymer Institute Brno (PIB) is a chemical research company and polymer additive masterbatch producer with long tradition that started
More informationHygienic evaluation of materials for the production of elastomers in contact with drinking water
Gummi Fasern Kunststoffe, 67, No. 11, 2014, pp. 697 701 Hygienic evaluation of materials for the production of elastomers in contact with drinking water R. Schuster Federal Environment Agency, Section
More informationMEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL MEDICAL DEVICES and IVDs ESSENTIAL PRINCIPLES of SAFETY & PERFORMANCE This guideline is intended to provide recommendations to applicants wishing to sell medical devices and IVDs
More informationGB/T / ISO :2007
Translated English of Chinese Standard: GB/T16886.6-2015 www.chinesestandard.net Sales@ChineseStandard.net GB NATIONAL STANDARD OF THE PEOPLE'S REPUBLIC OF CHINA ICS 11.040.01 C 30 GB/T 16886.6-2015 /
More informationRedefining the balance between processibility and chemical resistance. A new-generation copolyester
Redefining the balance between processibility and chemical resistance A new-generation copolyester Transforming the potential for medical-grade polymers Eastman has supplied a wide range of materials for
More informationPRIMARY PACKAGING. Influences the Results of E&L Studies
SCHOTT Pharma Services Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar How Sterilization of PRIMARY PACKAGING Influences the Results of E&L Studies As the demands that are being placed on
More informationMedidée Services SA. Nano-Tera.ch. 05 February 2015 part 8. PMA, 510k, IDE. Pierre-Alain Sommer
Nano-Tera.ch 05 February 2015 part 8 PMA, 510k, IDE Pierre-Alain Sommer Pierre-alain.sommer@medidee.com www.medidee.com Nano-Tera 2015 05.02.2015 USA/FDA Pre Market Approval System - PMA, Pre Market Notifcation
More informationCANADA (HEALTH CANADA)
1 GMP GAZETTE TM March 2015 HPFBI CANADA (HEALTH CANADA) Notice, Re: Regulatory Decision Summaries and Submissions Under Review Who s affected? Manufacturers of prescription drugs (pharmaceuticals and
More informationRadglo ICE TECHNICAL DATA SHEET 13/03/2019. General information. Fluorescent colors:
Radglo ICE General information General description: Daylight and ultra-violet responsive fluorescent pigments for water, solvent and oil based cosmetic applications. A dyed/pigmented thermoset polyester-amid
More informationSafety and sustainability in one package
Safety and sustainability in one package Styrene-free. Opportunity-rich. Eastman Eastalite copolyester is a sustainable alternative to high-impact polystyrene (HIPS) used for opaque rigid medical packaging.
More informationGuidance for Industry Compounding Animal Drugs from Bulk Drug Substances
#230 Guidance for Industry Compounding Animal Drugs from Bulk Drug Substances DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding this
More informationFuture of Question-based Review and Regulatory Submissions
Future of Question-based Review and Regulatory Submissions Robert Iser Associate Director for Policy Development (Acting) Office of Pharmaceutical Science / CDER / FDA FDA/PQRI Conference on Evolving Product
More informationContains Nonbinding Recommendations Draft - Not for Implementation
Reprinted from FDA s website by EAS Consulting Group, LLC Select Updates for Non-Clinical Engineering Tests and Recommended Labeling for Intravascular Stents and Associated Delivery Systems Draft Guidance
More informationMATERIAL SAFETY DATA SHEET
MATERIAL SAFETY DATA SHEET Issuing Date: 04-Dec-2013 Version 1 1. Product and Company Information Product ID: Product name Product Type Recommended Use Uses advised against 96531643_NA CG OutlastIluminaAlDayLipcolor
More informationMaterial Safety Data Sheet SECTION 1: PRODUCT AND COMPANY IDENTIFICATION SECTION 2: INGREDIENTS SECTION 3: HAZARDS IDENTIFICATION
Material Safety Data Sheet Copyright, 2006, 3M Company. All rights reserved. Copying and/or downloading of this information for the purpose of properly utilizing 3M products is allowed provided that: (1)
More informationRequired Biocompatibility Training and Toxicology Profiles for Evaluation of Medical Devices
Use of International Standard ISO-10993, 'Biological Evaluation of Medical Devices Part 1: Evaluation and Testing' (Replaces #G87-1 #8294) (blue book memo)(text Only) This guidance was written prior to
More informationTechnical requirements to Good Manufacturing Practice in metered dose inhalers production and development (2. part) Extractable - Leachable
Technical requirements to Good Manufacturing Practice in metered dose inhalers production and development (2. part) Extractable - Leachable Dr. Gyula Körtvélyessy UNIDO Honorary Secretary General of the
More informationontainer Closure Systems
C PharmaED s Register by July 1 st and receive a $300 Discount! ontainer Closure Systems Strategies for Selection, Compliance and Mitigation of Extractables and Leachables Challenges SEPTEMBER 15-16, 2008,
More informationA Generic Industry Perspective on Establishing Impurity Limits And a Corresponding Control Strategy
A Generic Industry Perspective on Establishing Impurity Limits And a Corresponding Control Strategy Nicholas Cappuccino, PhD Vice-President, Head of Quality and Scientific Affairs Dr. Reddy s Laboratories,
More informationGuidance for FDA Reviewers
Guidance for FDA Reviewers Premarket Notification Submissions for Empty Containers for the Collection and Processing of Blood and Blood Components Comments and suggestions regarding this document may be
More informationMediprene 500M. Transparent TPE Series
Mediprene 500M Transparent TPE Series CONTENTS INTRODUCTION KEY PROPERTIES RAW MATERIAL SELECTION TYPICAL APPLICATIONS COLOURED & TRANSPARENT COMPOUNDS GRADE TABLE PROCESSING CONTACTS INTRODUCTION The
More informationIssuing Date: 26-Feb-2015 Revision Date: 26-Feb-2015 Version 1 1. IDENTIFICATION. Finished Product - Consumer (Retail) Use Only
SAFETY DATA SHEET Issuing Date: 26-Feb-2015 Version 1 1. IDENTIFICATION Product Name Product ID: Product Type: Recommended Use Synonyms Olay Regenerist Luminous 2 in 1 Moisturizing 99677562_RET_NG Finished
More informationIssuing Date: 23-Feb-2015 Revision Date: 23-Feb-2015 Version 1 1. IDENTIFICATION. COVERGIRL outlast stay fabulous 3in1 foundation
SAFETY DATA SHEET Issuing Date: 23-Feb-2015 Version 1 1. IDENTIFICATION Product Name Product ID: Product Type: Recommended Use Synonyms COVERGIRL outlast stay fabulous 3in1 96847540_RET_NG Finished Product
More information